# of uses or occurrences | 2Â year period before TCM | During and after the courses of TCM | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Total | Ave./Year | Prior 3 M | 1-3 M | 4-6 M | 7-9 M | 10 – 12 M | 1 - 1.5 Y | 1.5- 2 Y | 2 - 2.5 Y | |
Patient 1 | ||||||||||
 Allergic Reactions | 100 | 50 | 10 | 8 | 3 | 3 | 2 | 1 | 1 | 0 |
 Epinephrine | 50 | 25 | 5 | 3 | 1 | 1 | 1 | 0 | 0 | 0 |
 Diphenhydramine (p.r.n.) | 100 | 50 | 10 | 8 | 3 | 3 | 2 | 1 | 1 | 0 |
 Prednisone | 50 | 25 | 5 | 5 | 1 | 1 | 1 | 0 | 0 | 0 |
 ER visits | 40 | 20 | 5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Patient 2 | ||||||||||
 Allergic Reactions | 30 | 15 | 10 | 1 | 2 | 1 | 0 | 0 | 0** | ND |
 Epinephrine | 34 | 17 | 10 | 0 | 0 | 0 | 0 | 0 | 0** | ND |
 Cetirizine (daily) | 730 | 365 | 93 | 30 | 0 | 0 | 0 | 0 | 0** | ND |
 Cetirizine (p.r.n.) | 30 | 15 | 10 | 1 | 0 | 0 | 0 | 0 | 0** | ND |
 Diphenhydramine (daily) | 730 | 365 | 93 | 30 | 0 | 0 | 0 | 0 | 0** | ND |
 Diphenhydramine (p.r.n.) | 30 | 15 | 10 | 1 | 1 | 1 | 0 | 0 | 0** | ND |
 Prednisone | 2 | NA* | 1 | 0 | 0 | 0 | 0 | 0 | 0** | ND |
 ER visits | 10 | 5 | 5 | 0 | 0 | 0 | 0 | 0 | 0** | ND |
Patient 3 | ||||||||||
 Allergic Reactions | 400 | 200 | 45 | 10 | 2 | 1 | ND | ND | ND | ND |
 Epinephrine | 5 | 2.5 | 2 | 1 | 0 | 0 | ND | ND | ND | ND |
 Diphenhydramine (p.r.n.) | 400 | 200 | 45 | 10 | 2 | 1 | ND | ND | ND | ND |
 Levocetirizine (daily) | 730 | 365 | 90 | 60 | 30 | 0 | ND | ND | ND | ND |
 Fexofenadine (daily) | 730 | 365 | 90 | 60 | 0 | 0 | ND | ND | ND | ND |
 Prednisone | 5 | 2.5 | 0 | 1 | 0 | 0 | ND | ND | ND | ND |
 ER visits | 5 | 2.5 | 1 | 1 | 0 | 0 | ND | ND | ND | ND |